Skip to main content
. Author manuscript; available in PMC: 2013 May 15.
Published in final edited form as: Bioorg Med Chem. 2012 Mar 29;20(10):3298–3305. doi: 10.1016/j.bmc.2012.03.043

Figure 5. Proteomic analysis for HER2 in breast cancer cell line (BTB-474) with azo-resin E.

Figure 5

W – whole cell lysate (BTB474); R – BTB474 lysate on Hsp90 Resin (resin E); R+ – BTB474 lysate pretreated with free drug, compound 5 (1 mM), before passing over Hsp90 resin (resin E). * Hsp90, ** HER2.